Brain‐derived neurotrophic factor levels in perinatal depression: A systematic review and meta‐analysis.
Saved in:
| Title: | Brain‐derived neurotrophic factor levels in perinatal depression: A systematic review and meta‐analysis. |
|---|---|
| Authors: | Jafarabady, Kyana (AUTHOR), Shafiee, Arman (AUTHOR), Bahri, Razman Arabzadeh (AUTHOR), Rajai Firouzabadi, Shahryar (AUTHOR), Mohammadi, Ida (AUTHOR), Amini, Mohammad Javad (AUTHOR) |
| Source: | Acta Psychiatrica Scandinavica. Nov2024, Vol. 150 Issue 5, p308-319. 12p. |
| Subjects: | Medical subject headings, Mental depression, Brain-derived neurotrophic factor, Database searching, Electronic information resource searching |
| Abstract: | Background: This systematic review and meta‐analysis aim to synthesize the available evidence and determine the overall brain‐derived neurotrophic factor (BDNF) levels in individuals diagnosed with perinatal depression (PND). Methods: We performed a thorough search of electronic databases, including PubMed, Embase, PsycINFO, and Web of Science, from their start until April 30, 2023. Our search strategy involved using specific keywords and medical subject headings (MeSH) terms related to BDNF, perinatal, post‐partum, and antepartum depression. In the meta‐analysis, we employed a random‐effects model, and subgroup analyses were conducted to investigate any variations in the results. Results: A total of 15 studies met the inclusion criteria, of which 10 were used in the quantitative analysis. The meta‐analysis demonstrated a significant decrease in BDNF levels in both individuals with antepartum depression (SMD: –0.31; 95% CI: −0.48 to −0.13; p‐value = 0.0008; I2 = 71%), and post‐partum depression (SMD: –0.61; 95% CI: −0.99 to −0.22; p‐value = 0.0002 I2 = 77%). Furthermore, a significantly higher rate of PND among individuals in the lowest BDNF quartile (OR: 2.64; 95% CI: 1.01 to 6.89; p‐value = 0.05; I2 = 90%) was seen. The results of subgroup analyses showed a statistically significant effect of the depression assessment tool on overall heterogeneity between studies. Conclusion: This systematic review and meta‐analysis provide evidence of lower BDNF protein levels in individuals diagnosed with PND. The results indicate that BDNF dysregulation may play a part in the development of PND. More research is needed to understand the mechanisms behind this and explore potential therapeutic applications. [ABSTRACT FROM AUTHOR] |
| Copyright of Acta Psychiatrica Scandinavica is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Background: This systematic review and meta‐analysis aim to synthesize the available evidence and determine the overall brain‐derived neurotrophic factor (BDNF) levels in individuals diagnosed with perinatal depression (PND). Methods: We performed a thorough search of electronic databases, including PubMed, Embase, PsycINFO, and Web of Science, from their start until April 30, 2023. Our search strategy involved using specific keywords and medical subject headings (MeSH) terms related to BDNF, perinatal, post‐partum, and antepartum depression. In the meta‐analysis, we employed a random‐effects model, and subgroup analyses were conducted to investigate any variations in the results. Results: A total of 15 studies met the inclusion criteria, of which 10 were used in the quantitative analysis. The meta‐analysis demonstrated a significant decrease in BDNF levels in both individuals with antepartum depression (SMD: –0.31; 95% CI: −0.48 to −0.13; p‐value = 0.0008; I2 = 71%), and post‐partum depression (SMD: –0.61; 95% CI: −0.99 to −0.22; p‐value = 0.0002 I2 = 77%). Furthermore, a significantly higher rate of PND among individuals in the lowest BDNF quartile (OR: 2.64; 95% CI: 1.01 to 6.89; p‐value = 0.05; I2 = 90%) was seen. The results of subgroup analyses showed a statistically significant effect of the depression assessment tool on overall heterogeneity between studies. Conclusion: This systematic review and meta‐analysis provide evidence of lower BDNF protein levels in individuals diagnosed with PND. The results indicate that BDNF dysregulation may play a part in the development of PND. More research is needed to understand the mechanisms behind this and explore potential therapeutic applications. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 0001690X |
| DOI: | 10.1111/acps.13632 |
